Document:

Exhibit 10.1 

 

Framework
Agreement on Strategic Cooperation

 

Party
A: Jin Xuan Luxury Tourism (Hainan) Digital Technology Co., Ltd.

 

Party
B: Chongqing EPet Technology Co., Ltd

 

Party
A and Party B (hereinafter collectively referred to as “both parties”) plan to establish a strategic cooperative relationship
based on the principle of equality, mutual benefit, and complementary advantages through friendly negotiation. Both parties shall integrate
advantageous resources on the basis of mutual benefit and establish a strategic partnership for long-term collaborative development.
Thus, the Framework Agreement on Strategic Cooperation is reached through friendly negotiation (hereinafter referred to as “this
Framework Agreement”) by both parties.

 

I.
Cooperation Principle

 

1.
Through the establishment of a close, long-term and friendly strategic cooperation partnership, both parties shall give full play to
their respective advantages. To carry out cooperation in pet food, pet commodity supply chain, cross-border trade, and other related
fields around the world, both parties shall contribute to further increase the overall market share, improve operational efficiency,
reduce operating costs, realize resource cooperation, complement each other’s advantages and achieve collaborative development.

 

2.
The basic principles of this Framework Agreement are voluntariness, equality, win-win, mutual benefit, mutual improvement, collaborative
development, adherence to trade secrets and joint market development.

 

3.
Both parties shall give full play to the advantages of both parties, complement each other, improve competitiveness, and jointly explore
the market.

 

4.
This Framework Agreement is an agreement that defines the basic principles of cooperation between both parties and shall serve as a guiding
document for long-term cooperation between both parties in the future as well as the basis for both parties to sign relevant contracts.

 

II.
Scope of Cooperation

 

This
Framework Agreement includes but is not limited to market development, customer loyalty program, and technical service cooperation between
Party A and Party B in pet food, pet commodity supply chain, cross-border trade, and other related fields around the world.

 

III.
Cooperation Content

 

1.
Both parties agree to be long-term strategic partners of each other. Party A is a cross-border trade sourcing company, Party B is an
e-commerce platform that has domestic industrial advantages. Both parties agreed to establish a strategic partnership, and reached the
cooperation approach as follows: Party B shall, under the same condition, grant Party A an exclusive right to supply cross-broader goods,
and entrust Party A to be responsible for and track the work related to cross-border business procurement. Under the same conditions,
Party A shall give priority to carrying out business-related cooperation with Party B. Both parties agree that the estimated annual purchase
quantity is as follows: From the effective date of this contract, the purchased quantity in the first year is about USD 60 million.

 

2.
For different procurement projects, Party A and Party B will sign relevant project contracts based on specific project conditions. Party
A shall, based on Party B’s requirements, provide Party B with a detailed quotation list, delivery time, logistics clearance, and
other services. Party B shall guarantee to complete the relevant work based on the quotation as required by Party A, and make sure that
the commodities or services, delivery time, and quality are in accordance with the provisions of the project contract.

 

3.
Party A and Party B may also choose to share resources and jointly develop new projects and new models based on their resources. Projects
jointly developed by both parties shall be supplemented by signing a new cooperation agreement according to the specific situation of
the project.

 

     

     

    

 

Iv.
Cooperation Approach

 

The
specific cooperation approach, content, price, and project delivery form shall be subject to the specific contract signed by both parties.

 

V.
Term of Cooperation

 

1.
Both parties are committed to establishing a long-term strategic cooperative relationship. If either party considers that the other party’s
behavior infringes upon its legitimate rights and interests, or for any other appropriate reason, the party may terminate this Framework
Agreement by consensus when the party deems it unnecessary or impossible to cooperate. In this situation, neither party shall be liable
for any legal liabilities and consequences. Upon termination of this Framework Agreement, both parties shall immediately stop the external
publicity in the name of the other party.

 

2.
If either party intends to terminate this Framework Agreement, the party shall negotiate with the other party at least one month in advance.

 

3.
If both parties agree to terminate this Framework Agreement, they shall continue to perform all project contracts signed during the cooperation
period until the performance of the project contract is completed, or they can terminate the project contracts upon mutual consent of
both parties.

 

VI.
Confidentiality Clause

 

Both
parties shall be obliged to keep confidentiality in terms of the business, technical information, and trade secrets of the other party
that they gain or hold in the course of business cooperation. The information shall not be disclosed to a third party without the written
consent of the other party. If either party breaches the confidentiality clause and leads to losses to the other party, the breaching
party shall bear corresponding economic and legal liabilities.

 

VII.
Contact Information

 

Communication
between the parties shall include but not limited to the following, and other contact information as notified in writing by the parties:

 

Party
A: JXLuxventure (Hainan) Technology Co., Ltd

Address:
[           ]

Contact
person: [           ]

E-mail:
[           ]

 

Party
B: Chongqing EPet Technology Co., Ltd

Address:
[           ]

Contact
person: [           ]

E-mail:
[           ]

 

The
parties to this Agreement may send documents to other parties by express delivery, in-person delivery, or E-mail.

 

    2

     

    

 

VIII.
Supplementary Articles

 

1.
This Framework Agreement is the basis of the strategic cooperation between both parties. In the condition that both parties subsequently
reach new matters or enter into specific contracts for cooperation, or if there is any discrepancy between the terms of the specific
contracts and the matters set forth in this Framework Agreement, the subsequent agreements and specific contracts shall prevail.

 

2.
The modification, termination, and other matters not covered herein shall be separately entered into by both parties in a supplementary
agreement upon mutual agreement.

 

3.
Disputes in connection with this Framework Agreement shall be settled by both parties through friendly negotiation. If the negotiation
fails, the dispute shall be under the jurisdiction of the People’s Court of the place where Party A is located.

 

4.
The Framework Agreement is made in duplicate, with each party holding one copy. The agreement shall come into force after being sealed
by both parties and have the same legal effect.

(No
text below)

 

Party
A (Seal):

Signed
by an authorized representative of the legal person:

Date:
March 21st, 2022

 

Party
B (Seal):

Signed
by an authorized representative of the legal person:

Date:
March 21st, 2022

 

 

3Document

Exhibit 4.4

Description of the Registrant’s Securities Registered Pursuant to
Section 12 of the Securities Exchange Act of 1934, as amended

The following summary of the general terms and provisions of the registered capital stock of 2seventy bio, Inc. (the “Company”, “we”, “our”) does not purport to be complete and is subject to, and qualified in its entirety by, reference to our Amended and Restated Certificate of Incorporation, or certificate of incorporation, our Amended and Restated Bylaws, or bylaws, each of which is filed with the Securities and Exchange Commission and incorporated by reference, and applicable provisions of the Delaware General Corporation Law, or the DGCL. The summaries below do not purport to be complete statements of the relevant provisions of the certificate of incorporation, the bylaws or the DGCL.
General
Our authorized capital stock consists of 200,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of preferred stock, par value $0.0001 per share, all of which shares of preferred stock are undesignated.
Common Stock
The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.
In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock. 
Our common stock is listed on The Nasdaq Global Select Market under the trading symbol “TSVT.”
The transfer agent and registrar for our common stock is American Stock Transfer & Trust Company, LLC.
Preferred Stock
Our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our Company or other corporate action. Immediately after consummation of this offering, no shares of preferred stock will be outstanding, and we have no present plan to issue any shares of preferred stock.
Anti-Takeover Effects of our Certificate of Incorporation and Bylaws and Delaware Law
Our certificate of incorporation and bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts. These provisions include the items described below.
Board Composition and Filling Vacancies
Our certificate of incorporation provides for the division of our board of directors into three classes serving staggered three-year terms, with one class being elected each year. Our certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of the holders of two-thirds or more of the shares then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of our board, may only be filled by the affirmative vote of a majority of our directors then in office even if less than a quorum. The classification of directors, together with the limitations on removal of directors and treatment of vacancies, has the effect of making it more difficult for stockholders to change the composition of our board of directors.
No Written Consent of Stockholders
			
	ACTIVE/115932700.2 

Our certificate of incorporation provides that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our bylaws or removal of directors by our stockholders without holding a meeting of stockholders.
Meetings of Stockholders
Our certificate of incorporation and bylaws provide that only a majority of the members of our board of directors then in office may call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our bylaws limit the business that may be conducted at an annual meeting of stockholders to those matters properly brought before the meeting.
Advance Notice Requirements
Our bylaws establish advance notice procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our bylaws specify the requirements as to form and content of all stockholders’ notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting.
Amendment to Certificate of Incorporation and Bylaws
Any amendment of our certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our certificate of incorporation, must thereafter be approved by a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions relating to stockholder action, board composition, and limitation of liability must be approved by not less than two-thirds of the outstanding shares entitled to vote on the amendment, and not less than two-thirds of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended or repealed by the affirmative vote of a majority of the directors then in office, subject to any limitations set forth in the bylaws; and may also be amended or repealed by the affirmative vote of at least seventy-five percent of the outstanding shares entitled to vote on the amendment or repeal, voting together as a single class, or, if our board of directors recommends that the stockholders approve or repeal the amendment, by the affirmative vote of the majority of the outstanding shares entitled to vote on the amendment or repeal, in each case voting together as a single class.
Undesignated Preferred Stock
Our certificate of incorporation provides for 10,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation grants our board of directors broad power to establish the rights and preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us.
Choice of Forum
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware, or the Chancery Court, will be the sole and exclusive forum for state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of, or a claim based on, a breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders, (iii) any action asserting a claim pursuant to any provision of the Delaware General Corporation Law, our certificate of incorporation or our bylaws, (iv) any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or bylaws, or (v) any action asserting a claim governed by the internal affairs doctrine, or the Delaware Forum Provision. The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act of 1933, as amended, or the Securities Act, or the Exchange Act. Our bylaws further provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or the Federal Forum Provision. Our bylaws provide that any person or entity purchasing or 
			
	ACTIVE/115932700.2 

otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the foregoing Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder.
Section 203 of the Delaware General Corporation Law
We are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:
•before the stockholder became interested, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;
•upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or
•at or after the time the stockholder became interested, the business combination was approved by our board of directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.
Section 203 defines a business combination to include:
•any merger or consolidation involving the corporation and the interested stockholder;
•any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;
•subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
•subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and
•the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges, or other financial benefits provided by or through the corporation.
In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.
Registration Rights
In connection with our separation from bluebird bio, Inc., or bluebird bio, we entered into an assumption agreement pursuant to which we assumed all of bluebird bio’s obligations (1) under the registration rights agreement that bluebird bio entered into on September 10, 2021 with certain institutional investors, solely in connection with the shares of our common stock that the institutional investors received in the distribution with respect to the shares of bluebird bio common stock they held as of the record date for the distribution and any shares of our Common Stock that the institutional investors receive upon exercise of the pre-funded warrants that we issued to such institutional investors in connection with the separation and pursuant to the terms of the securities purchase agreement, dated September 10, 2021, by and among bluebird bio and such institutional investors and (2) under Article IV of the securities purchase agreement in connection with the shares of our Common Stock that the institutional investors received in the distribution with respect to the shares of bluebird bio common stock they held as of the record date for the distribution and any shares of our common stock that the institutional investors receive upon exercise of the pre-funded warrants we issued to them. Pursuant to the registration rights agreement and the assumed provisions of the securities purchase agreement, following demand by any investor at any time such investor could reasonably be deemed to be an affiliate (as defined and used in Rule 144 as promulgated under the Securities Act) of the Company, to (i) file with the SEC a Registration Statement on Form S-3 covering the resale of the shares of our common stock issued to it in the distribution in respect of the purchased shares of bluebird bio common stock or issuable upon exercise of the pre-funded warrants by the investors as promptly as reasonably practicable following such demand, and in any event within 60 days after such demand, or (ii) to effect one underwritten offering per calendar year, but no more than three underwritten offerings in total, and no more than two underwritten offerings or block trades in any twelve month period.
Certain holders of our shares of our common stock will be entitled to rights with respect to the registration of these securities under the Securities Act. These rights are provided under the terms of a registration rights agreement between us and certain holders of our common stock. Pursuant to the registration rights agreement we will prepare and file a registration statement with the SEC within 45 calendar days following the March 17, 2022, and will use 
			
	ACTIVE/115932700.2 

our reasonable best efforts to cause this registration statement to be declared effective by the SEC within 30 calendar days thereafter (or within 45 calendar days thereafter if the SEC reviews the registration statement). We also agreed among other things, to indemnify the purchasers, their officers, directors, members, employees and agents, successors and assigns under the registration statement from certain liabilities and pay all fees and expenses (excluding any legal fees of the selling holder(s), and any underwriting discounts and selling commissions) incident to our obligations under the registration rights agreement. 
			
	ACTIVE/115932700.2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]